![Mark W. Womack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark W. Womack
Vorstandsvorsitzender bei
Selexis SA
Profil
Mark W.
Womack is currently Chief Executive Officer at Selexis SA since 2022.
Formerly, Mr. Womack was Chief Executive Officer at KBI Biopharma, Inc. from 2022 to 2023, Chief Executive Officer at OneSource Specialty Pharma Ltd., Chief Executive Officer at BioCina Pty Ltd. from 2023 to 2025, and Chief Business Officer at AGC Biologics, Inc.
Aktive Positionen von Mark W. Womack
| Unternehmen | Position | Beginn |
|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Vorstandsvorsitzender | 02.05.2022 |
Ehemalige bekannte Positionen von Mark W. Womack
| Unternehmen | Position | Ende |
|---|---|---|
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Vorstandsvorsitzender | 17.04.2023 |
| ONESOURCE SPECIALTY PHARMA LIMITED | Vorstandsvorsitzender | - |
AGC Biologics, Inc.
 AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
AGC Biologics, Inc.
AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Health Technology |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Commercial Services |
OneSource Specialty Pharma Ltd.
 OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics | Health Technology |
